• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项将体积性或临床乳腺钼靶密度纳入泰勒-库齐克乳腺癌风险模型的病例对照研究。

A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.

作者信息

Brentnall Adam R, Cohn Wendy F, Knaus William A, Yaffe Martin J, Cuzick Jack, Harvey Jennifer A

机构信息

Queen Mary University of London, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, London, UK.

University of Virginia, Public Health Sciences, University of Virginia Health Sciences Center, Charlottesville, VA.

出版信息

J Breast Imaging. 2019 Jun;1(2):99-106. doi: 10.1093/jbi/wbz006. Epub 2019 May 11.

DOI:10.1093/jbi/wbz006
PMID:31423486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6690422/
Abstract

BACKGROUND

Accurate breast cancer risk assessment for women attending routine screening is needed to guide screening and preventive interventions. We evaluated the accuracy of risk predictions from both visual and volumetric mammographic density combined with the Tyrer-Cuzick breast cancer risk model.

METHODS

A case-control study (474 patient participants and 2243 healthy control participants) of women aged 40-79 years was performed using self-reported classical risk factors. Breast density was measured by using automated volumetric software and Breast Imaging and Reporting Data System (BI-RADS) density categories. Odds ratios (95% CI) were estimated by using logistic regression, adjusted for age, demographic factors, and 10-year risk from the Tyrer-Cuzick model, for a change from the 25 to 75 percentile of the adjusted percent density distribution in control participants (IQ-OR).

RESULTS

After adjustment for classical risk factors in the Tyrer-Cuzick model, age, and body mass index (BMI), BI-RADS density had an IQ-OR of 1.55 (95% CI = 1.33 to 1.80) compared with 1.40 (95% CI = 1.21 to 1.60) for volumetric percent density. Fibroglandular volume (IQ-OR = 1.28, 95% CI = 1.12 to 1.47) was a weaker predictor than was BI-RADS density (P = 0.014) or volumetric percent density (P = 0.065). In this setting, 4.8% of women were at high risk (8% + 10-year risk), using the Tyrer-Cuzick model without density, and 7.1% (BI-RADS) compared with 6.8% (volumetric) when combined with density.

CONCLUSION

The addition of volumetric and visual mammographic density measures to classical risk factors improves risk stratification. A combined risk could be used to guide precision medicine, through risk-adapted screening and prevention strategies.

摘要

背景

需要对参加常规筛查的女性进行准确的乳腺癌风险评估,以指导筛查和预防干预措施。我们评估了视觉和体积乳腺X线密度与泰勒-库齐克乳腺癌风险模型相结合的风险预测准确性。

方法

对40-79岁女性进行病例对照研究(474名患者参与者和2243名健康对照参与者),采用自我报告的经典风险因素。使用自动体积软件和乳腺影像报告和数据系统(BI-RADS)密度分类来测量乳腺密度。通过逻辑回归估计比值比(95%可信区间),针对对照参与者调整百分比密度分布从第25百分位数到第75百分位数的变化(四分位数间距比值比),对年龄、人口统计学因素以及泰勒-库齐克模型的10年风险进行了调整。

结果

在对泰勒-库齐克模型中的经典风险因素、年龄和体重指数(BMI)进行调整后,BI-RADS密度的四分位数间距比值比为1.55(95%可信区间=1.33至1.80),而体积百分比密度为1.40(95%可信区间=1.21至1.60)。纤维腺体体积(四分位数间距比值比=1.28,95%可信区间=1.12至1.47)作为预测指标比BI-RADS密度(P=0.014)或体积百分比密度(P=0.065)弱。在这种情况下,不考虑密度因素时,使用泰勒-库齐克模型,4.8%的女性处于高风险(8%+10年风险),结合密度因素时,使用BI-RADS密度的为7.1%,使用体积密度的为6.8%。

结论

在经典风险因素中加入体积和视觉乳腺X线密度测量可改善风险分层。通过风险适应性筛查和预防策略,综合风险可用于指导精准医学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fbf/6690422/f78bc045b8ea/wbz006f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fbf/6690422/4cb462fd1445/wbz006f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fbf/6690422/f78bc045b8ea/wbz006f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fbf/6690422/4cb462fd1445/wbz006f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fbf/6690422/f78bc045b8ea/wbz006f0002.jpg

相似文献

1
A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.一项将体积性或临床乳腺钼靶密度纳入泰勒-库齐克乳腺癌风险模型的病例对照研究。
J Breast Imaging. 2019 Jun;1(2):99-106. doi: 10.1093/jbi/wbz006. Epub 2019 May 11.
2
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.经典风险因素与乳腺密度相结合的乳腺癌风险评估的长期准确性。
JAMA Oncol. 2018 Sep 1;4(9):e180174. doi: 10.1001/jamaoncol.2018.0174. Epub 2018 Sep 13.
3
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.在英国一个前瞻性筛查队列中,乳腺X线密度提高了泰勒-库齐克模型和盖尔乳腺癌风险模型的准确性。
Breast Cancer Res. 2015 Dec 1;17(1):147. doi: 10.1186/s13058-015-0653-5.
4
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.一项基于经典因素和乳腺密度的 143 个单核苷酸多态性用于乳腺癌风险分层的病例对照评估。
Int J Cancer. 2020 Apr 15;146(8):2122-2129. doi: 10.1002/ijc.32541. Epub 2019 Jul 13.
5
Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.采用半自动和全自动方法及乳腺影像报告和数据系统(BI-RADS)评估乳腺癌风险和乳腺钼靶密度
Radiology. 2017 Feb;282(2):348-355. doi: 10.1148/radiol.2016152062. Epub 2016 Sep 5.
6
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.乳腺钼靶密度可优化高危女性乳腺癌风险的 Tyrer-Cuzick 评估:国际乳腺癌干预研究 I 安慰剂组的研究结果
Breast Cancer Res. 2014 Oct 8;16(5):451. doi: 10.1186/s13058-014-0451-5.
7
A comparison of five methods of measuring mammographic density: a case-control study.五种测量乳腺密度方法的比较:病例对照研究。
Breast Cancer Res. 2018 Feb 5;20(1):10. doi: 10.1186/s13058-018-0932-z.
8
External validation of a mammographic texture marker for breast cancer risk in a case-control study.一项病例对照研究中用于乳腺癌风险的乳腺X线纹理标志物的外部验证
J Med Imaging (Bellingham). 2020 Jan;7(1):014003. doi: 10.1117/1.JMI.7.1.014003. Epub 2020 Feb 12.
9
Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.IBIS/Tyrer-Cuzick 乳腺癌风险模型在妇女健康倡议中的种族和民族表现。
Cancer. 2021 Oct 15;127(20):3742-3750. doi: 10.1002/cncr.33767. Epub 2021 Jul 6.
10
Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.应用受试者工作特征(ROC)曲线分析 Tyrer-Cuzick 和 Gail 在江西省乳腺癌筛查中的应用。
Med Sci Monit. 2018 Aug 9;24:5528-5532. doi: 10.12659/MSM.910108.

引用本文的文献

1
Cross-field strength and multi-vendor reliability of MagDensity for MRI-based quantitative breast density analysis.用于基于MRI的乳腺密度定量分析的磁密度的跨场强度和多供应商可靠性。
PLoS One. 2025 Jun 24;20(6):e0316076. doi: 10.1371/journal.pone.0316076. eCollection 2025.
2
Personalized screening based on risk and density: prevalence data from the RIBBS study.基于风险和密度的个性化筛查:RIBBS研究的患病率数据。
Radiol Med. 2025 Mar 21. doi: 10.1007/s11547-025-01981-5.
3
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

本文引用的文献

1
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.经典风险因素与乳腺密度相结合的乳腺癌风险评估的长期准确性。
JAMA Oncol. 2018 Sep 1;4(9):e180174. doi: 10.1001/jamaoncol.2018.0174. Epub 2018 Sep 13.
2
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.应用单核苷酸多态性和乳腺 X 线密度与经典危险因素预测乳腺癌风险。
JAMA Oncol. 2018 Apr 1;4(4):476-482. doi: 10.1001/jamaoncol.2017.4881.
3
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.
遗传性乳腺癌:综合风险评估与预防策略
Genes (Basel). 2025 Jan 13;16(1):82. doi: 10.3390/genes16010082.
4
Investigating the added value of incorporatingmammographic density to an integrated breastcancer risk model with questionnaire-based riskfactors and polygenic risk score.研究将乳腺X线密度纳入包含基于问卷的风险因素和多基因风险评分的综合乳腺癌风险模型中的附加价值。
Res Sq. 2024 Dec 19:rs.3.rs-5445786. doi: 10.21203/rs.3.rs-5445786/v1.
5
The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women.基于风险的乳腺筛查(RIBBS)研究方案:一种针对年轻女性的个性化筛查模式。
Radiol Med. 2024 May;129(5):727-736. doi: 10.1007/s11547-024-01797-9. Epub 2024 Mar 21.
6
Patterns and Predictors of Referral for Screening Breast MRI: A Mixed-Methods Study.筛查性乳腺 MRI 转诊的模式和预测因素:一项混合方法研究。
J Womens Health (Larchmt). 2024 May;33(5):639-649. doi: 10.1089/jwh.2023.0557. Epub 2024 Mar 14.
7
PREDICTION OF HEREDITARY CANCERS USING NEURAL NETWORKS.使用神经网络预测遗传性癌症
Ann Appl Stat. 2022 Mar;16(1):495-520. doi: 10.1214/21-aoas1510. Epub 2022 Mar 28.
8
Leveraging Comprehensive Health Records for Breast Cancer Risk Prediction: A Binational Assessment.利用综合健康记录进行乳腺癌风险预测:一项中澳评估。
AMIA Annu Symp Proc. 2023 Apr 29;2022:385-394. eCollection 2022.
9
Beyond Breast Density: Risk Measures for Breast Cancer in Multiple Imaging Modalities.超越乳腺密度:多种影像学模式下乳腺癌的风险评估指标。
Radiology. 2023 Mar;306(3):e222575. doi: 10.1148/radiol.222575. Epub 2023 Feb 7.
10
Feasibility Study and Clinical Impact of Incorporating Breast Tissue Density in High-Risk Breast Cancer Screening Assessment.纳入乳腺组织密度对高危乳腺癌筛查评估的可行性研究和临床影响。
Curr Oncol. 2022 Nov 15;29(11):8742-8750. doi: 10.3390/curroncol29110688.
乳腺癌风险模型:现有模型的全面概述、验证及临床应用。
Breast Cancer Res Treat. 2017 Jul;164(2):263-284. doi: 10.1007/s10549-017-4247-z. Epub 2017 Apr 25.
4
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.《1975 - 2012年美国癌症现状年度报告》,重点关注肝癌发病率上升情况
Cancer. 2016 May 1;122(9):1312-37. doi: 10.1002/cncr.29936. Epub 2016 Mar 9.
5
Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening.临床与自动乳腺密度测量的比较:对风险预测和补充筛查的意义。
Radiology. 2016 Jun;279(3):710-9. doi: 10.1148/radiol.2015151261. Epub 2015 Dec 22.
6
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis.影响乳腺癌化学预防药物摄取和依从性的因素:一项系统评价和荟萃分析
Ann Oncol. 2016 Apr;27(4):575-90. doi: 10.1093/annonc/mdv590. Epub 2015 Dec 8.
7
Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On.筛查对乳腺癌死亡率的影响:20年后的英国项目
Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):455-62. doi: 10.1158/1055-9965.EPI-15-0803. Epub 2015 Dec 8.
8
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.在英国一个前瞻性筛查队列中,乳腺X线密度提高了泰勒-库齐克模型和盖尔乳腺癌风险模型的准确性。
Breast Cancer Res. 2015 Dec 1;17(1):147. doi: 10.1186/s13058-015-0653-5.
9
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.平均风险女性的乳腺癌筛查:美国癌症协会2015年指南更新
JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783.
10
Reliability of automated breast density measurements.自动乳腺密度测量的可靠性。
Radiology. 2015 May;275(2):366-76. doi: 10.1148/radiol.15141686. Epub 2015 Feb 25.